United States Multi Cancer Early Detection Testing Market Set to Revolutionize Oncology with Breakthrough Innovations and Rising Global Demand 2025 | Major key players - GRAIL, Guardant Health, Exact Sciences.

Market Size and Growth:

The Global Multi Cancer Early Detection Testing Market size reached US$ 1.67 billion in 2023, with a rise of US$ 1.92 billion in 2024, and is expected to reach US$ 7.52 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.

The Multi Cancer Early Detection Testing Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Multi Cancer Early Detection Testing market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/multi-cancer-early-detection-testing-market?sz

The Multi-Cancer Early Detection (MCED) Testing Market refers to the healthcare segment focused on advanced diagnostic tests that identify multiple types of cancer at early stages through biomarkers, genetic profiling, and liquid biopsy techniques. These tests aim to improve survival rates, enable timely interventions, reduce treatment costs, and transform cancer care by offering comprehensive, non-invasive screening solutions.

Recent Key Developments of United States (U.S):

September 10, 2025: Exact Sciences launched its CancerguardTM test, a new MCED blood test available as a laboratory-developed test (LDT). The test analyzes multiple biomarker classes to detect various cancers, including those with no standard screening.

June 4, 2025: Legislation aimed at increasing early cancer detection for Medicare beneficiaries, the "Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act," gained bipartisan majority support in both the U.S. House and Senate.

August 2025: A study indicated that despite limited public awareness (16.8%) of MCED tests in 2024, there is a high perceived value (42.1%) for them, particularly among older adults, minority racial/ethnic populations, and those with a family history of cancer.

Ongoing 2025: The shift towards full device clearance and FDA approval for MCED tests is being encouraged by breakthrough pathways and synchronized Medicare reviews, potentially streamlining the path to nationwide reimbursement.

Ongoing 2025: Companies and health systems are increasingly offering MCED tests as a benefit, with at least one insurer, Curative, bundling a test into its employer plans in 2025, which can help self-insured employers manage future oncology costs.

Key Players:

Grail (Illumina)
Guardant Health
Exact Sciences
Burning Rock Biotech
Lucence Health
Foundation Medicine (Roche)
AnchorDx
Freenome
Niramai.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=multi-cancer-early-detection-testing-market

Market Segmentation:

By Test Type: Galleri Test, CancerSEEK, Others.

By Cancer Type: Breast Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer and Others.

By End User: Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/multi-cancer-early-detection-testing-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Multi Cancer Early Detection Testing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Multi Cancer Early Detection Testing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Multi Cancer Early Detection Testing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Multi Cancer Early Detection Testing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Multi Cancer Early Detection Testing Market in 2025?
◆ What is the projected growth rate of the Multi Cancer Early Detection Testing Market through 2033?
◆ Who are the key players in the Multi Cancer Early Detection Testing Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.